Literature DB >> 33668623

Prior Elicitation for Use in Clinical Trial Design and Analysis: A Literature Review.

Danila Azzolina1,2, Paola Berchialla3, Dario Gregori1, Ileana Baldi1.   

Abstract

Bayesian inference is increasingly popular in clinical trial design and analysis. The subjective knowledge derived from an expert elicitation procedure may be useful to define a prior probability distribution when no or limited data is available. This work aims to investigate the state-of-the-art Bayesian prior elicitation methods with a focus on clinical trial research. A literature search on the Current Index to Statistics (CIS), PubMed, and Web of Science (WOS) databases, considering "prior elicitation" as a search string, was run on 1 November 2020. Summary statistics and trend of publications over time were reported. Finally, a Latent Dirichlet Allocation (LDA) model was developed to recognise latent topics in the pertinent papers retrieved. A total of 460 documents pertinent to the Bayesian prior elicitation were identified. Of these, 213 (45.4%) were published in the "Probability and Statistics" area. A total of 42 articles pertain to clinical trial and the majority of them (81%) reports parametric techniques as elicitation method. The last decade has seen an increased interest in prior elicitation and the gap between theory and application getting narrower and narrower. Given the promising flexibility of non-parametric approaches to the experts' elicitation, more efforts are needed to ensure their diffusion also in applied settings.

Entities:  

Keywords:  clinical trial; latent dirichlet allocation; prior elicitation

Year:  2021        PMID: 33668623      PMCID: PMC7917693          DOI: 10.3390/ijerph18041833

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  49 in total

1.  Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data.

Authors:  John W Stevens; Anthony O'Hagan
Journal:  Int J Technol Assess Health Care       Date:  2002       Impact factor: 2.188

2.  Bayesian sample size determination for phase IIA clinical trials using historical data and semi-parametric prior's elicitation.

Authors:  Paola Berchialla; Sarah Zohar; Ileana Baldi
Journal:  Pharm Stat       Date:  2018-11-15       Impact factor: 1.894

3.  An evaluation of clinicians' subjective prior probability estimates.

Authors:  J G Dolan; D R Bordley; A I Mushlin
Journal:  Med Decis Making       Date:  1986 Oct-Dec       Impact factor: 2.583

4.  A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis.

Authors:  Erica N Browne; Sivakumar R Rathinam; Anuradha Kanakath; Radhika Thundikandy; Manohar Babu; Thomas M Lietman; Nisha R Acharya
Journal:  Ophthalmic Epidemiol       Date:  2016-12-16       Impact factor: 1.648

Review 5.  Better decision making in drug development through adoption of formal prior elicitation.

Authors:  Nigel Dallow; Nicky Best; Timothy H Montague
Journal:  Pharm Stat       Date:  2018-03-30       Impact factor: 1.894

6.  Evaluating the Impact of Prior Assumptions in Bayesian Biostatistics.

Authors:  Satoshi Morita; Peter F Thall; Peter Müller
Journal:  Stat Biosci       Date:  2010-07-01

7.  Bayesian methods for the design and interpretation of clinical trials in very rare diseases.

Authors:  Lisa V Hampson; John Whitehead; Despina Eleftheriou; Paul Brogan
Journal:  Stat Med       Date:  2014-06-23       Impact factor: 2.373

8.  Proposal for a Five-Step Method to Elicit Expert Judgment.

Authors:  Duco Veen; Diederick Stoel; Mariëlle Zondervan-Zwijnenburg; Rens van de Schoot
Journal:  Front Psychol       Date:  2017-12-05

9.  Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.

Authors:  A V Ramanan; L V Hampson; H Lythgoe; A P Jones; B Hardwick; H Hind; B Jacobs; D Vasileiou; I Wadsworth; N Ambrose; J Davidson; P J Ferguson; T Herlin; A Kavirayani; O G Killeen; S Compeyrot-Lacassagne; R M Laxer; M Roderick; J F Swart; C M Hedrich; M W Beresford
Journal:  PLoS One       Date:  2019-06-05       Impact factor: 3.240

10.  Elicitation of prior probability distributions for a proposed Bayesian randomized clinical trial of whole blood for trauma resuscitation.

Authors:  Jan O Jansen; Henry Wang; John B Holcomb; John A Harvin; Joshua Richman; Elenir Avritscher; Shannon W Stephens; Van Thi Thanh Truong; Marisa B Marques; Stacia M DeSantis; Jose-Miguel Yamal; Claudia Pedroza
Journal:  Transfusion       Date:  2020-01-22       Impact factor: 3.157

View more
  1 in total

1.  Remote, real-time expert elicitation to determine the prior probability distribution for Bayesian sample size determination in international randomised controlled trials: Bronchiolitis in Infants Placebo Versus Epinephrine and Dexamethasone (BIPED) study.

Authors:  Jingxian Lan; Amy C Plint; Stuart R Dalziel; Terry P Klassen; Martin Offringa; Anna Heath
Journal:  Trials       Date:  2022-04-11       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.